Aby wyświetlić tę treść, wymagana jest subskrypcja JoVE. Zaloguj się lub rozpocznij bezpłatny okres próbny.
Method Article
* Wspomniani autorzy wnieśli do projektu równy wkład.
We describe a novel method for the delivery of DNA plasmid into the urothelial cells of mouse bladder in vivo through urethra catheterization and electroporation. It offers a fast and convenient way for generating autochthonous mouse models of bladder diseases.
Genetically engineered mouse models (GEMMs) are extremely valuable in revealing novel biological insights into the initiation and progression mechanisms of human diseases such as cancer. Transgenic and conditional knockout mice have been frequently used for gene overexpression or ablation in specific tissues or cell types in vivo. However, generating germline mouse models can be time-consuming and costly. Recent advancements in gene editing technologies and the feasibility of delivering DNA plasmids by viral infection have enabled rapid generation of non-germline autochthonous mouse cancer models for several organs. The bladder is an organ that has been difficult for viral vectors to access, due to the presence of a glycosaminoglycan layer covering the urothelium. Here, we describe a novel method developed in lab for efficient delivery of DNA plasmids into the mouse bladder urothelium in vivo. Through intravesical instillation of pCAG-GFP DNA plasmid and electroporation of surgically exposed bladder, we show that the DNA plasmid can be delivered specifically into the bladder urothelial cells for transient expression. Our method provides a fast and convenient way for overexpression and knockdown of genes in the mouse bladder, and can be applied to building GEMMs of bladder cancer and other urological diseases.
Genetically engineered mouse models (GEMMs) have been playing an essential role in expanding our knowledge about animal development, gene functions in vivo, and mechanisms of disease progression1,2. Germline GEMMs are traditionally developed in two ways. The first is the creation of transgenic mice by pronuclear injection of DNA plasmid followed by the transplantation of zygotes into pseudopregnant females. The other is the generation of knock-out/knock-in mice by homologous recombination in embryonic stem cells and the development of chimeras. Conditional knockout of genes in specific tissue or cell type of interest involves the breeding of genetically engineered alleles with Cre and flox sites for multiple generations. The whole process can be expensive and time-consuming, especially if the goal is to target multiple genes tissue-specifically. Recently, gene-editing technologies such as clustered regularly interspaced short palindromic repeats (CRISPR) have been applied to several organs of the mice to induce tissue-specific genetic alterations for autochthonous cancer modeling3,4,5,6,7 or correct disease mutations in situ8,9. In these studies, the delivery of the gRNA vectors was usually achieved through adenoviral or lentiviral infection of the organ or hydrodynamic tail-vein injection. The relative ease of delivery of the CRISPR components to the lung and liver has greatly improved the convenience and efficiency of cancer modeling in these organs compared to the traditional Cre-Lox based mouse models.
The bladder urothelium is where most bladder tumors originate. The delivery of DNA vectors to the bladder urothelium for cancer modeling or gene therapy is hampered by a glycosaminoglycan layer on the apical urothelial surface, which acts as a barrier for adherence of infectious viruses10,11. Several pretreatment agents such as Syn3 and dodecyl-β-d-maltoside have been used to disrupt this barrier and enhance adenovirus infection efficiency12,13,14. Whether adeno-associated viruses (AAVs) can effectively infect the bladder has not been reported. Overall, a non-viral based delivery method would be desirable. Here, we describe a novel method developed in the lab for efficient DNA plasmid delivery to the mouse urothelium through urethra catheterization and electroporation. Because our approach does not involve chemical pretreatment of the glycosaminoglycan layer or virus production, it significantly simplifies the delivery of DNA plasmids into the mouse bladder urothelium, and should facilitate various in vivo studies of bladder diseases.
All procedures described here were performed in accordance with the guidelines and regulations from the Institutional Animal Care and Use Committee (IACUC) of University of California Santa Cruz.
1. Plasmid and Tools Preparation
2. Anaesthetizing Animal
3. Urine Depletion and Bladder Rinsing
4. Plasmid Delivery
5. Recovery
To demonstrate the success of gene delivery into the bladder urothelium, we used the pCAG-GFP15 plasmid for electroporation. 20 µL of plasmid and Trypan Blue solution was injected through the urethra and 5 electric pulses were administered. After 48 h, we dissected the mouse bladder and observed patches of GFP fluorescence under a dissection fluorescence microscope, whereas a negative control bladder that did not undergo electroporation showed no GFP signal (<...
Electroporation enhances the cell membrane permeability and is a powerful technology for gene electrotransfer16. Gene delivery into living rodents by electroporation has been frequently used in neurobiology fields17,18,19,20,21. Its potential applications in many other organs have not been extensively explored. To our knowledge, our met...
The authors declare no competing interest.
We thank Professor Bin Chen, Dr. Yue Zhang, and Kendy Hoang for help with setting up the electroporation system. This work was supported by grants from the Santa Cruz Cancer Benefit Group and NIH to Z.A.W.
Name | Company | Catalog Number | Comments |
BD 1mL TB Syringe | Fisher | 148232E | |
Buprenorphine | Sigma | B9275-50MG | |
Dumont Tweezers | Roboz Surgical Instr | RS-5005 | Treat with 70% ethanol before surgical use |
ECM830 SQ Wave Electroporator | Harvard Apparatus | 450052 | |
Exel International Disposable Safelet I.V. Catheters | Fisher Scientific | 14-841-21 | 24G, 2.11 cm length, 0.045 cm outer diameter |
Extra Fine Micro Dissecting Scissors | Roboz Surgical Instr | RS-5135 | Treat with 70% ethanol before surgical use |
Isoflurane | Vet one | 501017 | |
K&H Heated Resting Mat for Small Animals, 9 By 12 Inches | Amazon | n/a | Cover the heat mat with paper towels |
Ophthalmic ointment | Fisher | NC0849514 | |
PBS, pH7.4 | Life Technologies | 10010049 | |
Pipet tips 200 µL | USA Scientific | 1111-0206 | |
Pipet Tips, Universal Fit; 0.1 to 10 µL | Fisher | 02707438(CS) | |
PIPETMAN NEO P2 | Gilson | F144561 | |
PIPETMAN NEO P200N | Gilson | F144565 | |
plasmid CAG-GFP | Addgene | 16664 | |
Platinum tweezertrode 5 mm | Harvard Apparatus | 450489 | 5 mm diameter |
Scissors | Roboz Surgical Instr | RS-5880 | Treat with 70% ethanol before surgical use |
String cord | Amazon | n/a | Mandala Crafts 150D 210D 0.8mm 1mm leather sewing stitching flat waxed thread string cord |
Tape, Scotch | Fisher | 19047257 | |
Therio-gel Veterinary Lubricant | PBS animal health | 353-736 | |
Trypan Blue Stain | Life Technologies | 15250061 | |
V-1 Table top system anesthesia | VetEquip | 901806 | |
Vicryl violet suture 18" FS-2 cutting 5-0 | Fisher | NC0578475 | |
Walgreens Povidone Iodine 10% | Walgreens | 953982 | |
Wound clip | Fisher | 018045 | |
Wound clip applier | Fisher | 01804 |
Zapytaj o uprawnienia na użycie tekstu lub obrazów z tego artykułu JoVE
Zapytaj o uprawnieniaThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone